Nuvectis Pharma, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 4.1M | 5.1M | 5.8M | 3.6M | 3.7M | 4.5M | 2.8M | 2.9M |
| Operating Expenses | 6.3M | 7.6M | 7.8M | 6.6M | 5.6M | 6.4M | 4.4M | 4.6M |
| Operating Income | -6.3M | -7.6M | -7.8M | -6.6M | -5.6M | -6.4M | -4.4M | -4.6M |
| Other Income / Gains | 210K | 303K | 332K | 261K | 236K | 201K | 206K | 215K |
| Net Income | -6.0M | -7.3M | -7.5M | -6.3M | -5.3M | -6.2M | -4.2M | -4.4M |
| EPS (Diluted) | -0.26 | -0.31 | -0.44 | -0.30 | -0.27 | -0.34 | -0.24 | -0.26 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 2.2M | 2.5M | 2.0M | 3.0M | 1.9M | 2.0M | 1.5M | 1.7M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 2.2M | 2.5M | 2.0M | 3.0M | 1.9M | 2.0M | 1.5M | 1.7M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 6.3M | 7.6M | 7.8M | 6.6M | 5.6M | 6.4M | 4.4M | 4.6M |
| Interest Income | 210K | -829K | 332K | 261K | 236K | 201K | 206K | 215K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ebitda | -6.0M | -8.2M | -7.5M | -6.3M | -5.3M | -6.2M | -4.2M | -4.4M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -6.0M | -7.3M | -7.5M | -6.3M | -5.3M | -6.2M | -4.2M | -4.4M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.26 | -0.31 | -0.44 | -0.30 | -0.27 | -0.34 | -0.24 | -0.26 |
| Weighted Average Shs Out | 23.4M | 21.8M | 22.7M | 21.4M | 19.9M | 19.5M | 17.2M | 16.9M |
| Weighted Average Shs Out Dil | 23.4M | 21.8M | 22.7M | 21.4M | 19.9M | 19.5M | 17.2M | 16.9M |